+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Eprosartan (CAS 133040-01-4) Global Market Research Report 2024

  • PDF Icon

    Report

  • 50 Pages
  • November 2024
  • Region: Global
  • Merchant Research and Consulting Ltd
  • ID: 4172388
Description Jump to:
This global report is a result of industry experts’ diligent work on researching the world market of Eprosartan. The report helps to build up a clear view of the market trends and developments, identify major players in the industry, and estimate main downstream sectors.

The Eprosartan global market report's key points:

  • Eprosartan description, applications and related patterns
  • Eprosartan market situation
  • Eprosartan manufacturers and distributors
  • Eprosartan prices
  • Eprosartan end-users
  • Eprosartan downstream industries trends
The first chapter introduces the product (composition, structure, hazards, storage, toxicological & ecological information, etc.).

The second chapter focuses on Eprosartan end-uses. The third chapter summarizes data about manufacturing methods.

The fourth chapter is about the related patents. The fifth chapter deals with Eprosartan market trends and forecast, distinguish Eprosartan manufacturers and suppliers.

The sixth chapter provides Eprosartan prices data.

The seventh chapter analyses Eprosartan downstream markets.


This product will be delivered within 5-7 business days.

Table of Contents

1. EPROSARTAN GENERAL INFORMATION
1.1. General information, synonyms
1.2. Composition, chemical structure
1.3. Safety information
1.4. Hazards identification
1.5. Handling and storage
1.6. Toxicological & ecological information
1.7. Transport information

2. EPROSARTAN APPLICATIONS

3. EPROSARTAN MANUFACTURING METHODS

4. EPROSARTAN PATENTS

5. EPROSARTAN MARKET WORLDWIDE
5.1. Global Eprosartan market analysis: market constraints, drivers and opportunities
5.2. Manufacturers of Eprosartan
  • Europe
  • Asia
  • North America
  • Etc.
5.3. Suppliers of Eprosartan
  • Europe
  • Asia
  • North America
  • Etc.
5.4. Market forecast

6. EPROSARTAN MARKET PRICES
  • Europe
  • Asia
  • North America
7. EPROSARTAN END-USE SECTOR

Related Topics

Related Reports

Medicinal Chemistry of Drugs Affecting Cardiovascular and Endocrine Systems - Product Image

Medicinal Chemistry of Drugs Affecting Cardiovascular and Endocrine Systems

  • Book
Berbamine (CAS 478-61-5) Global Market Research Report 2024 - Product Image

Berbamine (CAS 478-61-5) Global Market Research Report 2024

  • Report
  • 50 Pages
  • Global
From
Budralazine (CAS 36798-79-5) Global Market Research Report 2024 - Product Image

Budralazine (CAS 36798-79-5) Global Market Research Report 2024

  • Report
  • 50 Pages
  • Global
From
Esmolol Hydrochloride Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Esmolol Hydrochloride Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 80 Pages
  • Global
From
Amyl Nitrite Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Amyl Nitrite Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 90 Pages
  • Global
From

About the Eprosartan Market

Eprosartan is a type of cardiovascular drug used to treat hypertension, or high blood pressure. It is an angiotensin II receptor antagonist, meaning it works by blocking the action of a hormone that causes blood vessels to narrow. This helps to reduce blood pressure and improve blood flow. It is usually taken once a day, with or without food. Common side effects include dizziness, headache, and fatigue. Eprosartan is available in both generic and brand-name forms. It is typically prescribed as part of a combination therapy, along with other medications such as diuretics and beta-blockers. It is also sometimes used to treat heart failure and kidney disease. The eprosartan market is highly competitive, with many companies offering generic and brand-name versions of the drug. Some of the major players in the market include Mylan, Teva Pharmaceuticals, Sandoz, and Lupin Pharmaceuticals. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.